Empagliflozin—A New Chance for Patients with Chronic Heart Failure

The heart failure (HF) epidemic is one of the challenges that has been faced by the healthcare system worldwide for almost 25 years. With an ageing world population and a fast-paced lifestyle that promotes the development of cardiovascular disease, the number of people suffering from heart failure w...

Full description

Bibliographic Details
Main Authors: Klaudia Kowalska, Justyna Walczak, Joanna Femlak, Ewelina Młynarska, Beata Franczyk, Jacek Rysz
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/1/47